Targeting DNA methyltransferases in non-small-cell lung cancer
- 1 August 2022
- journal article
- research article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 83, 77-87
Abstract
No abstract availableKeywords
Funding Information
- Leverhulme Trust (RPG-2016-014)
This publication has 196 references indexed in Scilit:
- Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated ProteinsJournal of Breast Cancer, 2013
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancersInternational Journal of Cancer, 2011
- Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early‐stage nonsmall cell lung cancersCancer, 2010
- Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemiaAnnals of Hematology, 2010
- Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosisOncogene, 2010
- BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non‐small cell lung cancerThe Journal of Pathology, 2010
- The Epigenomics of CancerCell, 2007
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- Flavonoids: Promising anticancer agentsMedicinal Research Reviews, 2003